Clinocopathologic Factors Affecting Actual 5-year Survival Rate of
Invasive Ductal Carcinoma: a Single-center Analysis of 365 Patients |
Chan-Ik Park1, JeeYeon Lee1, SangHwa Ko1, ChangIn Choi1, SangHyup Lee2, Hyung-il Seo1, YoungTae Bae1 |
1Department of Surgery, Breast Clinic, Pusan National University Hospital, College of Medicine, Busan, Republic of Korea 2Department of Surgery, Pusan National University Yangsan Hospital |
침윤성 유관암에 있어 실제 5년 생존율에 관여하는 임상병리학적 인자: 365명을 대상으로 한 단일 기관 연구 |
박찬익1, 이지연1, 고상화1, 최창인1, 이상협2, 서형일1, 배영태1 |
1부산대학교 의학전문대학원 외과학교실, 유방클리닉 2양산부산대학교병원 외과학교실 |
Corresponding Author:
YoungTae Bae ,Tel: +82-51-240-7238, Fax: +82-51-247-1365, Email: bytae@pusan.ac.kr |
Received: September 23, 2011; Accepted: October 20, 2011. |
|
Share :
|
ABSTRACT |
Background The aim of this study is to figure out the clinicopathologic factors of invasive ductal carcinoma
affecting to actual 5-year survival rate(5-YSR).
Patients and Methods From Jan of 1999 to Dec of 2003, a total of 365 female patients with invasive ductal
carcinoma who undergone operations in Pusan National University Hospital were enrolled for this study. The
univariate and multivariate analysis were performed with clinicopathologic factors and actual 5-YSR.
Results The mean age of patients was 47.6 years and mean follow-up period was 62.8 months. Thirty-nine of the
365 patients had expired within 5 years after operation and the actual 5-YSR was 89.3%. The variables affecting to
actual 5-YSR of breast cancer in univariate analysis were preoperative CA 15-3 level(p=0.0211), tumor
size(p<0.0000), axillary lymph nodes metastasis(p<0.0000), pathologic cancer stage(p<0.0000),
lymphovascular(p=0.0004) and perineural invasion(p=0.0192) of primary tumor, positivity of progesterone
receptor(p=0.0457) and HER2-neu gene(p=0.0179), breast-conserving surgery(p<0.0000), perioperative
transfusion(p=0.0002), neoadjuvant and adjuvant chemotherapy(p<0.0000), treatment with tamoxifen(p=0.0380).
But, in multivariate analysis, significant factors with actual 5-YSR were only pathologic tumor stage(p=0.0012) and
adjuvant chemotherapy(p=0.0102).
Conclusion The pathologic tumor stage and adjuvant chemotherapy were related with actual 5-YSR of invasive
ductal carcinoma significantly. The adjuvant chemotherapy should be selected carefully with considering
clinicopathologic factors of breast cancer, because various combinations are possible even if the pathologic tumor
stage is difficult to change by physician. |
Keywords:
Clinicopathologic factors | Actual 5-year survival rate | Invasive ductal carcinoma |
|
|
|